Cargando…
41.2 WHAT DOES EPIDEMIOLOGICAL DATA TELL US ABOUT CLOZAPINE’S EFFECTIVENESS?
BACKGROUND: The patients included in RCTs represent a small atypical minority of the entire patient population, as up to 80–90% of patients are excluded because of mental or physical comorbidity, suicidal or antisocial behaviour, or substance abuse. Concerning clozapine, this means that those most s...
Autor principal: | Tiihonen, Jari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888327/ http://dx.doi.org/10.1093/schbul/sby014.170 |
Ejemplares similares
-
41.1 WHAT DO META-ANALYSES TELL US ABOUT CLOZAPINE’S EFFICACY AND EFFECTIVENESS FOR TREATMENT REFRACTORY SCHIZOPHRENIA?
por: Siskind, Dan, et al.
Publicado: (2018) -
What does the immunometabolic status tell us about depression?
por: Lopez-Garcia, P.
Publicado: (2023) -
Caregiving in the U.S. 2020: What Does the Latest Edition of This Survey Tell Us About Their Contributions and Needs?
por: Prudencio, Gabriela, et al.
Publicado: (2020) -
PM412. Emergence of Tardive Dyskinesia upon Clozapine Treatment: A Case Report
por: Moon, Sun-Young, et al.
Publicado: (2016) -
Kawasaki disease: What is the epidemiology telling us about the etiology?
por: Burgner, David, et al.
Publicado: (2005)